On the public citation graph
Anti-TNF therapy: past, present and future
0 signed · 632 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/1521-4141(200109)31:9<2566::aid-immu2566>3.0.co;2-lopenalex-snapshot
Inhibition of tumor necrosis factor reduces the severity of virus-specific lung immunopathology
inferredcites →https://doi.org/10.1002/1529-0131(199809)41:9<1552::aid-art5>3.0.co;2-wopenalex-snapshot
Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor ? monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis
inferredcites →https://doi.org/10.1002/1529-0131(200001)43:1<38::aid-anr6>3.0.co;2-lopenalex-snapshot
Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor α blockade in patients with rheumatoid arthritis
inferredcites →https://doi.org/10.1002/1529-0131(200011)43:11<2383::aid-anr2>3.0.co;2-dopenalex-snapshot
Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor α: Findings in open-label and randomized placebo-controlled trials
inferredcites →https://doi.org/10.1002/art.10697openalex-snapshot
Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial
inferredcites →https://doi.org/10.1002/art.1780361206openalex-snapshot
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α
inferredcites →https://doi.org/10.1002/art.20221openalex-snapshot
Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate
inferredcites →https://doi.org/10.1002/art.20576openalex-snapshot
Safety and efficacy of tumor necrosis factor α blockade in systemic lupus erythematosus: An open‐label study
inferredcites →https://doi.org/10.1002/art.21405openalex-snapshot
Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial
inferredcites →https://doi.org/10.1002/art.22718openalex-snapshot
Infliximab and methotrexate as induction therapy in patients with early rheumatoid arthritis
inferredcites →https://doi.org/10.1002/art.22983openalex-snapshot
Peptidyl arginine deiminase type 2 (PAD‐2) and PAD‐4 but not PAD‐1, PAD‐3, and PAD‐6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation
inferredcites →https://doi.org/10.1002/art.38755openalex-snapshot
Selective Tumor Necrosis Factor Receptor I Blockade Is Antiinflammatory and Reveals Immunoregulatory Role of Tumor Necrosis Factor Receptor II in Collagen‐Induced Arthritis
inferredcites →https://doi.org/10.1002/eji.1830211039openalex-snapshot
Expression of granulocyte‐macrophage colony‐stimulating factor in rheumatoid arthritis: Regulation by tumor necrosis factor‐α
inferredcites →https://doi.org/10.1002/jcp.22167openalex-snapshot
Post‐transcriptional regulation of α‐smooth muscle actin determines the contractile phenotype of Dupuytren's nodular cells
inferredcites →https://doi.org/10.1016/j.amjmed.2003.09.039openalex-snapshot
Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti–tumor necrosis factor therapy
inferredcites →https://doi.org/10.1016/j.clim.2014.01.005openalex-snapshot
Targeting fibroblast-like synovial cells at sites of inflammation with peptide targeted liposomes results in inhibition of experimental arthritis
inferredcites →https://doi.org/10.1016/s0140-6736(00)80009-4openalex-snapshot
Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock
inferredcites →https://doi.org/10.1016/s0140-6736(83)90629-3openalex-snapshot
ROLE OF ABERRANT HLA-DR EXPRESSION AND ANTIGEN PRESENTATION IN INDUCTION OF ENDOCRINE AUTOIMMUNITY
inferredcites →https://doi.org/10.1016/s0140-6736(89)90430-3openalex-snapshot
INHIBITORY EFFECT OF TNF$alpha; ANTIBODIES ON SYNOVIAL CELL INTERLEUKIN-1 PRODUCTION IN RHEUMATOID ARTHRITIS
inferredcites →https://doi.org/10.1016/s0140-6736(94)90628-9openalex-snapshot
Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis
inferredcites →https://doi.org/10.1016/s0140-6736(94)90632-7openalex-snapshot
Repeated therapy with monoclonal antibody to tumour necrosis factor α (cA2) in patients with rheumatoid arthritis
inferredcites →https://doi.org/10.1016/s0140-6736(97)07382-0openalex-snapshot
Long-term postoperative cognitive dysfunction in the elderly: ISPOCD1 study
inferredcites →https://doi.org/10.1038/labinvest.3780127openalex-snapshot
Treatment with Soluble VEGF Receptor Reduces Disease Severity in Murine Collagen-Induced Arthritis
inferredcites →https://doi.org/10.1038/nature11307openalex-snapshot
TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis
inferredcites →https://doi.org/10.1038/newbio237013a0openalex-snapshot
Specific Collaboration between T and B Lymphocytes across a Cell Impermeable Membrane in vitro
inferredcites →https://doi.org/10.1056/nejm199901283400401openalex-snapshot
A Trial of Etanercept, a Recombinant Tumor Necrosis Factor Receptor:Fc Fusion Protein, in Patients with Rheumatoid Arthritis Receiving Methotrexate
inferredcites →https://doi.org/10.1056/nejm200011303432202openalex-snapshot
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
inferredcites →https://doi.org/10.1056/nejmoa032691openalex-snapshot
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
inferredcites →https://doi.org/10.1056/nejmoa050524openalex-snapshot
Abatacept for Rheumatoid Arthritis Refractory to Tumor Necrosis Factor α Inhibition
inferredcites →https://doi.org/10.1056/nejmoa0810866openalex-snapshot
Injectable Collagenase Clostridium Histolyticum for Dupuytren's Contracture
inferredcites →https://doi.org/10.1073/pnas.1014557107openalex-snapshot
Tumor necrosis factor-α triggers a cytokine cascade yielding postoperative cognitive decline
inferredcites →https://doi.org/10.1073/pnas.1018501108openalex-snapshot
TNF-α promotes fracture repair by augmenting the recruitment and differentiation of muscle-derived stromal cells
inferredcites →https://doi.org/10.1073/pnas.1301100110openalex-snapshot
Unraveling the signaling pathways promoting fibrosis in Dupuytren's disease reveals TNF as a therapeutic target
inferredcites →https://doi.org/10.1073/pnas.72.9.3666openalex-snapshot
An endotoxin-induced serum factor that causes necrosis of tumors.
inferredcites →https://doi.org/10.1073/pnas.89.20.9784openalex-snapshot
Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.
inferredcites →https://doi.org/10.1084/jem.170.5.1627openalex-snapshot
Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia.
inferredcites →https://doi.org/10.1084/jem.20040435openalex-snapshot
Tumor Necrosis Factor (TNF) Receptor Shedding Controls Thresholds of Innate Immune Activation That Balance Opposing TNF Functions in Infectious and Inflammatory Diseases
inferredcites →https://doi.org/10.1093/oseo/instance.00043218openalex-snapshot
An Inquiry into the Nature and Causes of the Wealth of Nations
inferredcites →https://doi.org/10.1097/00000542-200703000-00007openalex-snapshot
Postoperative Impairment of Cognitive Function in Rats
inferredcites →https://doi.org/10.1101/sqb.2013.78.022905openalex-snapshot
The Promised Land of Human Immunology
inferredcites →https://doi.org/10.1126/science.3895437openalex-snapshot
Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of Endotoxin
inferredcites →https://doi.org/10.1136/ard.2006.055111openalex-snapshot
Selective costimulation modulation using abatacept in patients with active rheumatoid arthritis while receiving etanercept: a randomised clinical trial
inferredcites →https://doi.org/10.1136/ard.2007.085787openalex-snapshot
Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies
inferredcites →https://doi.org/10.1136/ard.2007.087106openalex-snapshot
Efficacy, safety and patient-reported outcomes of combination etanercept and sulfasalazine versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised 2-year study
inferredcites →https://doi.org/10.1136/ard.2008.092932openalex-snapshot
IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial
inferredcites →https://doi.org/10.1146/annurev.immunol.14.1.397openalex-snapshot
ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS
inferredcites →https://doi.org/10.1152/ajplung.00304.2004openalex-snapshot
Pulmonary inflammation induced by high-stretch ventilation is mediated by tumor necrosis factor signaling in mice
inferredcites →https://doi.org/10.1161/01.cir.0000077913.60364.d2openalex-snapshot
Randomized, Double-Blind, Placebo-Controlled, Pilot Trial of Infliximab, a Chimeric Monoclonal Antibody to Tumor Necrosis Factor-α, in Patients With Moderate-to-Severe Heart Failure
inferredcites →https://doi.org/10.1161/01.cir.0000124490.27666.b2openalex-snapshot
Targeted Anticytokine Therapy in Patients With Chronic Heart Failure
inferredcites →https://doi.org/10.1161/circulationaha.109.851881openalex-snapshot
Toll-Like Receptor-2 Mediates Inflammation and Matrix Degradation in Human Atherosclerosis
inferredcites →https://doi.org/10.1172/jci116446openalex-snapshot
Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression.
inferredcites →https://doi.org/10.1186/cc9019openalex-snapshot
The impact of IL-1 modulation on the development of lipopolysaccharide-induced cognitive dysfunction
inferredcites →https://doi.org/10.1371/journal.ppat.1003627openalex-snapshot
Porphyromonas gingivalis Facilitates the Development and Progression of Destructive Arthritis through Its Unique Bacterial Peptidylarginine Deiminase (PAD)
inferredcites →https://doi.org/10.3109/17453674.2013.878831openalex-snapshot
Similar mortality rates in hip fracture patients over the past 31 years
inferredcites →https://doi.org/10.4049/jimmunol.163.3.1521openalex-snapshot
Regulation of Cytokines, Cytokine Inhibitors, and Acute-Phase Proteins Following Anti-TNF-α Therapy in Rheumatoid Arthritis
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4169244openalex-extracted
Acute and Chronic Tnf-α-Induced Effects on Hematopoietic Stem Cells are Fully Reversible
inferred← citeshttps://doi.org/10.1002/9781683674023.ch31openalex-snapshot
Overview of the Cytokine Assay Multiverse
inferred← citeshttps://doi.org/10.1002/acr2.90136openalex-snapshot
Signaling Pathway–Biomarker Coupling for Precision Therapy in Rheumatoid Arthritis: Mechanistic Insights, Translational Bottlenecks, and Emerging Strategies
inferred← citeshttps://doi.org/10.1002/adfm.202405133openalex-snapshot
Regulatory T Cells and Their Derived Cell Pharmaceuticals as Emerging Therapeutics Against Autoimmune Diseases
inferred← citeshttps://doi.org/10.1002/ange.202306274openalex-snapshot
Synthetic Peptide Antibodies as TNF‐α Inhibitors: Molecularly Imprinted Polymer Nanogels Neutralize the Inflammatory Activity of TNF‐α in THP‐1 Derived Macrophages
inferred← citeshttps://doi.org/10.1002/anie.202306274openalex-snapshot
Synthetic Peptide Antibodies as TNF‐α Inhibitors: Molecularly Imprinted Polymer Nanogels Neutralize the Inflammatory Activity of TNF‐α in THP‐1 Derived Macrophages
inferred← citeshttps://doi.org/10.1002/art.39446openalex-snapshot
Amelioration of Experimental Autoimmune Arthritis Through Targeting of Synovial Fibroblasts by Intraarticular Delivery of MicroRNAs 140‐3p and 140‐5p
inferred← citeshttps://doi.org/10.1002/art.40413openalex-snapshot
Selective Activation of Tumor Necrosis Factor Receptor II Induces Antiinflammatory Responses and Alleviates Experimental Arthritis
inferred← citeshttps://doi.org/10.1002/bit.27730openalex-snapshot
Gene switch for l ‐glucose‐induced biopharmaceutical production in mammalian cells
inferred← citeshttps://doi.org/10.1002/cbin.12154openalex-snapshot
Fibroblast activation protein promotes progression of hepatocellular carcinoma via regulating the immunity
inferred← citeshttps://doi.org/10.1002/cpdd.1135openalex-snapshot
A Randomized, Double‐Blind, Parallel Controlled, Single‐Dose Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of the Infliximab Biosimilar CMAB008 and the Reference Product in Healthy Chinese Male Subjects
inferred← citeshttps://doi.org/10.1002/cpdd.738openalex-snapshot
Pharmacokinetic Similarity of ABP 710, a Proposed Biosimilar to Infliximab: Results From a Randomized, Single‐Blind, Single‐Dose, Parallel‐Group Study in Healthy Subjects
inferred← citeshttps://doi.org/10.1002/cpt.3655openalex-snapshot
First‐in‐Human Single and Multiple Ascending Dose Studies of Balinatunfib, a Small Molecule Inhibitor of TNFR1 Signaling in Healthy Participants
inferred← citeshttps://doi.org/10.1002/cpt.980openalex-snapshot
Potent Anti‐Inflammatory and Pro‐Resolving Effects of Anabasum in a Human Model of Self‐Resolving Acute Inflammation
inferred← citeshttps://doi.org/10.1002/eji.201746938openalex-snapshot
Model answers: Rational application of murine models in arthritis research
inferred← citeshttps://doi.org/10.1002/eji.202048922openalex-snapshot
JAK inhibitors: Ten years after
inferred← citeshttps://doi.org/10.1002/jbmr.4447openalex-snapshot
TNF-Polarized Macrophages Produce Insulin-like 6 Peptide to Stimulate Bone Formation in Rheumatoid Arthritis in Mice
inferred← citeshttps://doi.org/10.1002/jcb.30680openalex-snapshot
A Snapshot of Cytokine Dynamics: A Fine Balance Between Health and Disease
inferred← citeshttps://doi.org/10.1002/jgh3.70385openalex-snapshot
Loss of Response to Anti‐Tumor Necrosis Factor Alpha Therapy in Patients With Inflammatory Bowel Disease: A Real‐World Comparison of Combination Therapy Versus Monotherapy
inferred← citeshttps://doi.org/10.1002/jlb.3vmr0219-069ropenalex-snapshot
Novel functions of inactive rhomboid proteins in immunity and disease
inferred← citeshttps://doi.org/10.1002/pds.5682openalex-snapshot
Implementation of risk minimization measures to reduce the risk of tuberculosis among tumor necrosis factor medication users
inferred← citeshttps://doi.org/10.1002/prp2.422openalex-snapshot
Application of nSMOL coupled with LC ‐ MS bioanalysis for monitoring the Fc‐fusion biopharmaceuticals Etanercept and Abatacept in human serum
inferred← citeshttps://doi.org/10.1002/smll.202202604openalex-snapshot
Radicals Scavenging MOFs Enabling Targeting Delivery of siRNA for Rheumatoid Arthritis Therapy
inferred← citeshttps://doi.org/10.1002/smll.202402141openalex-snapshot
Dual‐Drug Nanomedicine Assembly with Synergistic Anti‐Aneurysmal Effects via Inflammation Suppression and Extracellular Matrix Stabilization
inferred← citeshttps://doi.org/10.1007/164_2019_323openalex-snapshot
Monoclonal Antibodies: Past, Present and Future
inferred← citeshttps://doi.org/10.1007/82_2020_208openalex-snapshot
Chronic Inflammation in Mucosal Tissues: Barrier Integrity, Inducible Lymphoid Tissues, and Immune Surveillance
inferred← citeshttps://doi.org/10.1007/978-1-0716-3754-8_4openalex-snapshot
Posttranscriptional Events Orchestrate Immune Homeostasis of CD8+ T Cells
inferred← citeshttps://doi.org/10.1007/978-1-4939-8559-3_20openalex-snapshot
Establishment of a Modified Collagen-Induced Arthritis Mouse Model to Investigate the Anti-inflammatory Activity of Progranulin in Inflammatory Arthritis
inferred← citeshttps://doi.org/10.1007/978-3-032-07868-1_20openalex-snapshot
Immune Modulating and Immunosuppressive Drugs
inferred← citeshttps://doi.org/10.1007/978-981-15-6407-9_13openalex-snapshot
TNF–TNFR2 Signal Plays a Decisive Role in the Activation of CD4+Foxp3+ Regulatory T Cells: Implications in the Treatment of Autoimmune Diseases and Cancer
inferred← citeshttps://doi.org/10.1007/978-981-16-7200-2_1openalex-snapshot
A Historical Introduction to the Biological Response Modifier Drugs: The ‘Biologicals’
inferred← citeshttps://doi.org/10.1007/s00068-023-02388-5openalex-snapshot
Traumatic inflammatory response: pathophysiological role and clinical value of cytokines
inferred← citeshttps://doi.org/10.1007/s00109-024-02494-wopenalex-snapshot
Therapy concepts in type 1 diabetes mellitus treatment: disease modifying versus curative approaches
inferred← citeshttps://doi.org/10.1007/s00210-024-03397-wopenalex-snapshot
Can infliximab serve as a new therapy for neuropsychiatric symptoms?
inferred← citeshttps://doi.org/10.1007/s00262-024-03788-1openalex-snapshot
Chimeric antigen receptor dendritic cells targeted delivery of a single tumoricidal factor for cancer immunotherapy
inferred← citeshttps://doi.org/10.1007/s00296-017-3861-8openalex-snapshot
Pyoderma gangrenosum and pyogenic arthritis presenting as severe sepsis in a rheumatoid arthritis patient treated with golimumab
inferred← citeshttps://doi.org/10.1007/s00296-019-04498-zopenalex-snapshot
Drug reactions in children with rheumatic diseases receiving parenteral therapies: 9 years’ experience of a tertiary pediatric rheumatology center
inferred← citeshttps://doi.org/10.1007/s00405-019-05716-xopenalex-snapshot
Intratympanic infliximab is a safe and effective rescue therapy for refractory immune-mediated hearing loss
inferred← citeshttps://doi.org/10.1007/s00408-016-9946-4openalex-snapshot
Intermittent Hypoxia Contributes to the Lung Damage by Increased Oxidative Stress, Inflammation, and Disbalance in Protease/Antiprotease System
inferred← citeshttps://doi.org/10.1007/s00436-023-08033-9openalex-snapshot
Ileal inflammation is reduced due to treatment with a metalloprotease from BmooMP-α-I snake venom in an experimental model of Toxoplasma gondii infection
inferred← citeshttps://doi.org/10.1007/s10067-017-3573-1openalex-snapshot
Is secukinumab a safe alternative treatment for ankylosing spondylitis with Guillain Barré syndrome after anti-TNF-α treatment? Case report and literature review
inferred← citeshttps://doi.org/10.1007/s10067-019-04684-1openalex-snapshot
Defining response to TNF-inhibitors in rheumatoid arthritis: the negative impact of anti-TNF cycling and the need for a personalized medicine approach to identify primary non-responders
inferred← citeshttps://doi.org/10.1007/s10067-020-05235-9openalex-snapshot
Intra-articular injection of etanercept versus glucocorticoids in rheumatoid arthritis patients
inferred← citeshttps://doi.org/10.1007/s10067-020-05420-wopenalex-snapshot
Treatment of rheumatic immune-related adverse events due to cancer immunotherapy with immune checkpoint inhibitors—is it time for a paradigm shift?
inferred← citeshttps://doi.org/10.1007/s10068-024-01772-0openalex-snapshot
Food allergens in immune systems
inferred← citeshttps://doi.org/10.1007/s10456-023-09876-7openalex-snapshot
Pathological angiogenesis: mechanisms and therapeutic strategies
inferred← citeshttps://doi.org/10.1007/s10571-021-01063-wopenalex-snapshot
TNF-α Triggers RIP1/FADD/Caspase-8-Mediated Apoptosis of Astrocytes and RIP3/MLKL-Mediated Necroptosis of Neurons Induced by Angiostrongylus cantonensis Infection
inferred← citeshttps://doi.org/10.1007/s10620-018-5144-yopenalex-snapshot
Comparison of Point-of-Care and Classical Immunoassays for the Monitoring Infliximab and Antibodies Against Infliximab in IBD
inferred← citeshttps://doi.org/10.1007/s10620-021-07378-4openalex-snapshot
Advancing Biologic Therapy for Refractory Autoimmune Hepatitis
inferred← citeshttps://doi.org/10.1007/s10753-018-0808-5openalex-snapshot
Anti-inflammatory Effect of Somatostatin Analogue Octreotide on Rheumatoid Arthritis Synoviocytes
inferred← citeshttps://doi.org/10.1007/s10753-026-02492-9openalex-snapshot
Selective Inhibition of Tumor Necrosis Factor for Attenuating Alzheimer’s Disease: Strategies Targeting Neuroinflammation
inferred← citeshttps://doi.org/10.1007/s10787-026-02322-2openalex-snapshot
Harmaline and the gut–brain–immune axis: a novel therapeutic avenue in neuroinflammation and ulcerative colitis
inferred← citeshttps://doi.org/10.1007/s10930-024-10188-yopenalex-snapshot
Immunosuppressive Cyclotides: A Promising Approach for Treating Autoimmune Diseases
inferred← citeshttps://doi.org/10.1007/s11010-025-05379-9openalex-snapshot
Inflammation in cardiovascular-kidney-metabolic syndrome: key roles and underlying mechanisms–a comprehensive review
inferred← citeshttps://doi.org/10.1007/s11033-024-10028-3openalex-snapshot
Leukocyte infiltration and cross-talk with cardiomyocytes exploit intracellular stress pathways in dilated cardiomyopathy of idiopathic origin
inferred← citeshttps://doi.org/10.1007/s11033-026-11602-7openalex-snapshot
Role of macrophages and dendritic cells in autoimmune diseases: a specific focus on tumor necrosis factor targeting therapies against rheumatoid arthritis
inferred← citeshttps://doi.org/10.1007/s11655-022-3517-0openalex-snapshot
Anti-inflammatory Effects of Ampelopsis Japonica Root on Contact Dermatitis in Mice
inferred← citeshttps://doi.org/10.1007/s11892-019-1144-3openalex-snapshot
Current Status on Immunological Therapies for Type 1 Diabetes Mellitus
inferred← citeshttps://doi.org/10.1007/s12016-015-8519-2openalex-snapshot
Macrophage Polarization and Bone Formation: A review
inferred← citeshttps://doi.org/10.1007/s12026-018-8997-4openalex-snapshot
A new CHO (Chinese hamster ovary)-derived cell line expressing anti-TNFα monoclonal antibody with biosimilar potential
inferred← citeshttps://doi.org/10.1007/s12026-025-09663-0openalex-snapshot
PS77: a novel peptide with α-helical structure for targeted anti-inflammatory therapy in biomaterials design
inferred← citeshttps://doi.org/10.1007/s12035-024-04464-2openalex-snapshot
The Aging Immune System: A Critical Attack on Ischemic Stroke
inferred← citeshttps://doi.org/10.1007/s12247-026-10916-0openalex-snapshot
Chemical Profiling and Therapeutic Investigations on Grewia gamblei J.R. Drumm for Potential Antioxidant and Anti-inflammatory Applications: An in vitro and in silico Approach
inferred← citeshttps://doi.org/10.1007/s12265-020-09964-9openalex-snapshot
Cardiovascular Risk Assessment and Therapeutic Implications in Rheumatoid Arthritis
inferred← citeshttps://doi.org/10.1007/s12325-018-0869-8openalex-snapshot
Long-Term Efficacy of Tumor Necrosis Factor Inhibitors for the Treatment of Methotrexate-Naïve Rheumatoid Arthritis: Systematic Literature Review and Meta-Analysis
inferred← citeshttps://doi.org/10.1007/s12325-022-02173-7openalex-snapshot
Discontinuation and Switchback After Non-Medical Switching from Originator Tumor Necrosis Factor Alpha (TNF) Inhibitors to Biosimilars: A Meta-Analysis of Real-World Studies from 2012 to 2018
inferred← citeshttps://doi.org/10.1007/s12414-017-0281-3openalex-snapshot
Biologicals in de praktijk van de reumatoloog
inferred← citeshttps://doi.org/10.1007/s40268-017-0211-yopenalex-snapshot
Pharmacokinetic Effects of Antidrug Antibodies Occurring in Healthy Subjects After a Single Dose of Intravenous Infliximab
inferred← citeshttps://doi.org/10.1007/s40272-020-00394-3openalex-snapshot
The Use of TNFα Inhibitors in Treating Pediatric Skin Disorders
inferred← citeshttps://doi.org/10.1007/s40290-026-00629-7openalex-snapshot
Impact of Regional Healthcare Policy Interventions on Biosimilar Use: A 10-year Evaluation of TNFα Inhibitors Utilization in Italy
inferred← citeshttps://doi.org/10.1007/s40744-023-00563-zopenalex-snapshot
Hematologic Malignancy Risk in Inflammatory Arthritis Patients Treated with TNF Inhibitors: The Real-Life Data from the HUR-BIO Registry
inferred← citeshttps://doi.org/10.1007/s43440-020-00068-4openalex-snapshot
mRNA level of ROCK1, RHOA, and LIMK2 as genes associated with apoptosis in evaluation of effectiveness of adalimumab treatment
inferred← citeshttps://doi.org/10.1016/b978-0-12-803302-9.00001-4openalex-snapshot
Pharmacological Strategies Using Biologics as Immunomodulatory Agents
inferred← citeshttps://doi.org/10.1016/b978-0-12-815762-6.00010-xopenalex-snapshot
Clinical trials of promising apoptosis modulating drugs
inferred← citeshttps://doi.org/10.1016/b978-0-12-822546-2.00024-1openalex-snapshot
Venous diseases including thromboembolic phenomena
inferred← citeshttps://doi.org/10.1016/b978-0-443-13947-5.00019-1openalex-snapshot
Role of regulatory T cells in pathogenesis and therapeutics of rheumatoid arthritis and juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.1016/b978-0-443-43946-9.00006-9openalex-snapshot
Nano-immunotherapy for the management of COPD
inferred← citeshttps://doi.org/10.1016/b978-0-7020-8165-1.00085-xopenalex-snapshot
Protein Kinase Antagonists
inferred← citeshttps://doi.org/10.1016/bs.apcsb.2019.08.009openalex-snapshot
Inflammatory bowel disease and targeted oral anti-TNF α therapy
inferred← citeshttps://doi.org/10.1016/j.addr.2017.05.017openalex-snapshot
Therapeutic pro-fibrogenic signaling pathways in fibroblasts
inferred← citeshttps://doi.org/10.1016/j.arr.2022.101618openalex-snapshot
Reducing neuroinflammation via therapeutic compounds and lifestyle to prevent or delay progression of Parkinson’s disease
inferred← citeshttps://doi.org/10.1016/j.arr.2024.102602openalex-snapshot
The cross-talk between the cGAS-STING signaling pathway and chronic inflammation in the development of musculoskeletal disorders
inferred← citeshttps://doi.org/10.1016/j.atherosclerosis.2021.09.024openalex-snapshot
Targeting cytokines and immune checkpoints in atherosclerosis with monoclonal antibodies
inferred← citeshttps://doi.org/10.1016/j.autrev.2025.103816openalex-snapshot
The role of CRISPR-Cas9 and CRISPR interference technologies in the treatment of autoimmune diseases
inferred← citeshttps://doi.org/10.1016/j.autrev.2025.103914openalex-snapshot
In search of biomarkers for prediction of drug treatment responses in rheumatoid arthritis: Lessons learned and future perspectives
inferred← citeshttps://doi.org/10.1016/j.bbcan.2020.188450openalex-snapshot
HOX genes and the NF-κB pathway: A convergence of developmental biology, inflammation and cancer biology
inferred← citeshttps://doi.org/10.1016/j.bbi.2019.06.021openalex-snapshot
Exogenous activation of tumor necrosis factor receptor 2 promotes recovery from sensory and motor disease in a model of multiple sclerosis
inferred← citeshttps://doi.org/10.1016/j.bbrc.2023.149411openalex-snapshot
Berberine alleviates inflammation and suppresses PLA2-COX-2-PGE2-EP2 pathway through targeting gut microbiota in DSS-induced ulcerative colitis
inferred← citeshttps://doi.org/10.1016/j.bcp.2016.07.010openalex-snapshot
The glucocorticoid budesonide has protective and deleterious effects in experimental colitis in mice
inferred← citeshttps://doi.org/10.1016/j.bcp.2021.114869openalex-snapshot
Anti-inflammatory, but not osteoprotective, effect of the TRAF6/CD40 inhibitor 6877002 in rodent models of local and systemic osteolysis
inferred← citeshttps://doi.org/10.1016/j.bcp.2026.117727openalex-snapshot
Structural and molecular characterization of a small-molecule TNF-α–TNFR1 inhibitor modulating cell death signaling
inferred← citeshttps://doi.org/10.1016/j.beha.2025.101615openalex-snapshot
Endogenous and exogenous cytokines: An overview and introduction
inferred← citeshttps://doi.org/10.1016/j.berh.2018.02.003openalex-snapshot
Update on research and clinical translation on specific clinical areas from biology to bedside: Unpacking the mysteries of juvenile idiopathic arthritis pathogenesis
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2021.121160openalex-snapshot
Interleukin-4-carrying small extracellular vesicles with a high potential as anti-inflammatory therapeutics based on modulation of macrophage function
inferred← citeshttps://doi.org/10.1016/j.bioorg.2020.104130openalex-snapshot
Inhibition of colitis by ring-modified analogues of 6-acetamido-2,4,5-trimethylpyridin-3-ol
inferred← citeshttps://doi.org/10.1016/j.biopha.2021.111785openalex-snapshot
Therapeutic use of specific tumour necrosis factor inhibitors in inflammatory diseases including COVID-19
inferred← citeshttps://doi.org/10.1016/j.biopha.2021.112181openalex-snapshot
Jiangzhi Granule attenuates non-alcoholic steatohepatitis by suppressing TNF/NFκB signaling pathway-a study based on network pharmacology
inferred← citeshttps://doi.org/10.1016/j.bmc.2021.116035openalex-snapshot
Synthesis and biological evaluation of a ring analogs of the selective CB2 inverse agonist SMM-189
inferred← citeshttps://doi.org/10.1016/j.bmcl.2021.128229openalex-snapshot
Small molecule approaches to treat autoimmune and inflammatory diseases (Part III): Targeting cytokines and cytokine receptor complexes
inferred← citeshttps://doi.org/10.1016/j.brainresbull.2024.110885openalex-snapshot
Tumor necrosis factor receptor 2 activation elicits sex-specific effects on cortical myelin proteins and functional recovery in a model of multiple sclerosis
inferred← citeshttps://doi.org/10.1016/j.cell.2020.03.007openalex-snapshot
Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases
inferred← citeshttps://doi.org/10.1016/j.cellimm.2018.12.006openalex-snapshot
Targeting antigen presentation in autoimmunity
inferred← citeshttps://doi.org/10.1016/j.cellimm.2020.104193openalex-snapshot
Regulatory T cell therapy: Current and future design perspectives
inferred← citeshttps://doi.org/10.1016/j.cellsig.2023.110656openalex-snapshot
Deciphering the molecular mechanism of the THBS1 gene in the TNF signaling axis in glioma stem cells
inferred← citeshttps://doi.org/10.1016/j.celrep.2024.114099openalex-snapshot
Antibodies targeting the shared cytokine receptor IL-1 receptor accessory protein invoke distinct mechanisms to block all cytokine signaling
inferred← citeshttps://doi.org/10.1016/j.clim.2019.06.006openalex-snapshot
Potential therapeutic applications of exosomes in different autoimmune diseases
inferred← citeshttps://doi.org/10.1016/j.clim.2024.110170openalex-snapshot
Tumor-necrosis factor α-rich environment alters type-I interferon response to viral stimuli in patients with juvenile idiopathic arthritis by altering myeloid dendritic cell phenotype
inferred← citeshttps://doi.org/10.1016/j.cmet.2020.06.013openalex-snapshot
The World Goes Bats: Living Longer and Tolerating Viruses
inferred← citeshttps://doi.org/10.1016/j.coms.2016.03.011openalex-snapshot
Medication Treatment Efficacy and Chronic Orofacial Pain
inferred← citeshttps://doi.org/10.1016/j.csbj.2024.03.026openalex-snapshot
The molecular subtypes of autoimmune diseases
inferred← citeshttps://doi.org/10.1016/j.cyto.2015.08.260openalex-snapshot
The role of cytokines in the pathogenesis of rheumatoid arthritis – Practical and potential application of cytokines as biomarkers and targets of personalized therapy
inferred← citeshttps://doi.org/10.1016/j.cyto.2016.08.027openalex-snapshot
TNFR signalling and its clinical implications
inferred← citeshttps://doi.org/10.1016/j.cyto.2017.05.004openalex-snapshot
How much have we learnt about the TNF family of cytokines?
inferred← citeshttps://doi.org/10.1016/j.cyto.2018.05.036openalex-snapshot
Activated human Foxp3+ regulatory T cells produce membrane-bound TNF
inferred← citeshttps://doi.org/10.1016/j.cyto.2024.156846openalex-snapshot
Kaempferol: Unveiling its anti-inflammatory properties for therapeutic innovation
inferred← citeshttps://doi.org/10.1016/j.cyto.2025.156933openalex-snapshot
The role of TNF in metabolic disorders and liver diseases
inferred← citeshttps://doi.org/10.1016/j.ebiom.2022.103824openalex-snapshot
Mendelian randomization study on the causal effects of tumor necrosis factor inhibition on coronary artery disease and ischemic stroke among the general population
inferred← citeshttps://doi.org/10.1016/j.ebiom.2023.104840openalex-snapshot
Allosteric TYK2 inhibition: redefining autoimmune disease therapy beyond JAK1-3 inhibitors
inferred← citeshttps://doi.org/10.1016/j.ejmech.2021.113867openalex-snapshot
Imidazo[1,2-b]pyridazine as privileged scaffold in medicinal chemistry: An extensive review
inferred← citeshttps://doi.org/10.1016/j.ejphar.2021.174500openalex-snapshot
Angiogenesis as a potential treatment strategy for rheumatoid arthritis
inferred← citeshttps://doi.org/10.1016/j.ejps.2023.106409openalex-snapshot
Dissolving microneedle patches-mediated percutaneous delivery of tetramethylpyrazine for rheumatoid arthritis treatment
inferred← citeshttps://doi.org/10.1016/j.ejpsy.2023.03.003openalex-snapshot
High molar ratios of tumor necrosis factor α (TNF α) soluble receptors I and II to the TNF ligand in human plasma from male veterans with comorbid posttraumatic stress disorder (PTSD) and mild traumatic brain injury (mTBI)
inferred← citeshttps://doi.org/10.1016/j.ejr.2023.04.001openalex-snapshot
Leukocytoclastic vasculitis induced by adalimumab biosimilar in an elderly female with rheumatoid arthritis: A case-based review
inferred← citeshttps://doi.org/10.1016/j.fsi.2023.108808openalex-snapshot
Shark VNAR phage display libraries: An alternative source for therapeutic and diagnostic recombinant antibody fragments
inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e38460openalex-snapshot
Recent advances and research progress regarding monoclonal antibodies for chronic graft-versus-host disease
inferred← citeshttps://doi.org/10.1016/j.heliyon.2025.e41965openalex-snapshot
Fatal toxoplasmic encephalitis triggered by anti-TNF therapy
inferred← citeshttps://doi.org/10.1016/j.hermed.2021.100422openalex-snapshot
An Open label, phase II clinical study to evaluate the efficacy and safety of DPOR/JR2007 in osteoarthritis of knee
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2017.02.052openalex-snapshot
Expression analysis and ATR-FTIR characterization of the secondary structure of recombinant human TNF-α from Escherichia coli SHuffle ® T7 Express and BL21 (DE3) cells
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2020.12.131openalex-snapshot
Vaccine targeting TNF epitope 1–14 do not suppress host defense against Mycobacterium bovis Bacillus Calmette-Guérin infection
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2024.137935openalex-snapshot
Exploring the impact of 2-hydroxyestradiol on heme oxygenase-1 to combat oxidative stress in rheumatoid arthritis
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2023.122646openalex-snapshot
Physicochemical characterization and functionality comparison of Humira®(adalimumab), Remicade®(infliximab) and Simponi Aria®(golimumab)
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2024.124713openalex-snapshot
Polypropylene sulfide methotrexate nanoparticles target the synovial lymphatic system to restore immune tolerance in rheumatoid arthritis
inferred← citeshttps://doi.org/10.1016/j.immuni.2016.04.019openalex-snapshot
The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory Responses
inferred← citeshttps://doi.org/10.1016/j.imu.2023.101415openalex-snapshot
Compositional and functional alteration of gut microbiota profiles in response to anti-TNF-α therapy in inflammatory bowel disease: A Pilot study
inferred← citeshttps://doi.org/10.1016/j.intimp.2019.03.064openalex-snapshot
New therapeutic strategies based on IL-2 to modulate Treg cells for autoimmune diseases
inferred← citeshttps://doi.org/10.1016/j.intimp.2019.105807openalex-snapshot
A randomized controlled dose-escalation study of SSS07, a humanized rabbit anti-human TNF alpha antibody, in healthy Chinese adults
inferred← citeshttps://doi.org/10.1016/j.intimp.2019.105914openalex-snapshot
Therapeutic treatment of a novel selective JAK3/JAK1/TBK1 inhibitor, CS12192, in rat and mouse models of rheumatoid arthritis
inferred← citeshttps://doi.org/10.1016/j.intimp.2023.110297openalex-snapshot
IL-10 in combination with IL-12 and TNF-α attenuates CXCL8/CXCR1 axis in peritoneal macrophages of mice infected with Staphylococcus aureus through the TNFR1-IL-1R-NF-κB pathway
inferred← citeshttps://doi.org/10.1016/j.isci.2023.106341openalex-snapshot
Temporal dynamics of TNF-mediated changes in hematopoietic stem cell function and recovery
inferred← citeshttps://doi.org/10.1016/j.isci.2023.107452openalex-snapshot
Injectable hydrogel particles for amorphous solid formulation of biologics
inferred← citeshttps://doi.org/10.1016/j.jaci.2017.11.024openalex-snapshot
TNF-α–induced protein 3 (TNFAIP3)/A20 acts as a master switch in TNF-α blockade–driven IL-17A expression
inferred← citeshttps://doi.org/10.1016/j.jad.2024.04.016openalex-snapshot
Lower levels of TRAF1 in Brodmann's area 24, but not 46, in bipolar disorders are not detectable in major depressive disorders
inferred← citeshttps://doi.org/10.1016/j.jaut.2021.102597openalex-snapshot
TLR expression profiles are a function of disease status in rheumatoid arthritis and experimental arthritis
inferred← citeshttps://doi.org/10.1016/j.jbc.2024.108043openalex-snapshot
Apoptotic signaling by TNFR1 is inhibited by the α2-6 sialylation, but not α2-3 sialylation, of the TNFR1 N-glycans
inferred← citeshttps://doi.org/10.1016/j.jcmgh.2019.10.006openalex-snapshot
Novel Human NKCC1 Mutations Cause Defects in Goblet Cell Mucus Secretion and Chronic Inflammation
inferred← citeshttps://doi.org/10.1016/j.jconrel.2020.12.025openalex-snapshot
Local drug delivery systems for inflammatory diseases: Status quo, challenges, and opportunities
inferred← citeshttps://doi.org/10.1016/j.jconrel.2022.08.016openalex-snapshot
Electrospun patch delivery of anti-TNFα F(ab) for the treatment of inflammatory oral mucosal disease
inferred← citeshttps://doi.org/10.1016/j.jdermsci.2015.06.016openalex-snapshot
Dexamethasone but not tacrolimus suppresses TNF-α-induced thymic stromal lymphopoietin expression in lesional keratinocytes of atopic dermatitis model
inferred← citeshttps://doi.org/10.1016/j.jep.2020.113147openalex-snapshot
Therapeutic potential of prenylated stilbenoid macasiamenene F through its anti-inflammatory and cytoprotective effects on LPS-challenged monocytes and microglia
inferred← citeshttps://doi.org/10.1016/j.jep.2026.121518openalex-snapshot
Effect and mechanism of compound Nujia honey paste on chronic unpredictable mild stress (CUMS) depression rats based on network pharmacology analysis
inferred← citeshttps://doi.org/10.1016/j.jfo.2022.04.009openalex-snapshot
Infliximab therapy in Behçet's uveitis
inferred← citeshttps://doi.org/10.1016/j.jobcr.2021.02.009openalex-snapshot
Exploring the role of immunotherapeutic drugs in autoimmune diseases: A comprehensive review
inferred← citeshttps://doi.org/10.1016/j.jtos.2023.08.004openalex-snapshot
TNF is a critical cytokine in age-related dry eye disease
inferred← citeshttps://doi.org/10.1016/j.lfs.2020.117545openalex-snapshot
Infliximab prevents dysfunction of the vas deferens by suppressing inflammation and oxidative stress in rats with chronic stress
inferred← citeshttps://doi.org/10.1016/j.mad.2019.111206openalex-snapshot
AISA can control the inflammatory facet of SASP
inferred← citeshttps://doi.org/10.1016/j.medj.2020.11.005openalex-snapshot
The Potential for Repurposing Anti-TNF as a Therapy for the Treatment of COVID-19
inferred← citeshttps://doi.org/10.1016/j.molimm.2017.11.016openalex-snapshot
Role of extracellular vesicles in rheumatoid arthritis
inferred← citeshttps://doi.org/10.1016/j.mporth.2022.06.007openalex-snapshot
Molecular biology: a guide for orthopaedic surgeons
inferred← citeshttps://doi.org/10.1016/j.mtbio.2026.103336openalex-snapshot
De novo design of dual-target mini-binders simultaneously neutralizing Streptococcus equi subspecies zooepidemicus M-like protein and host TNFR1 confers complete protection against lethal infection
inferred← citeshttps://doi.org/10.1016/j.mtnano.2026.100941openalex-snapshot
Nanodrug-mediated strategies for targeting the undruggable: Comparative perspectives on targeted protein degradation and stabilization
inferred← citeshttps://doi.org/10.1016/j.nanoso.2024.101365openalex-snapshot
Advancements in nanoparticles-based therapies for biomedical applications
inferred← citeshttps://doi.org/10.1016/j.omtn.2020.01.014openalex-snapshot
Downregulation of Hypoxia-Inducible Factor-1α by RNA Interference Alleviates the Development of Collagen-Induced Arthritis in Rats
inferred← citeshttps://doi.org/10.1016/j.pharep.2018.12.005openalex-snapshot
Beneficial anti-inflammatory effects of combined rosuvastatin and cilostazol in a TNF-driven inflammatory model
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2016.03.006openalex-snapshot
Emerging pharmacologic targets and treatments for myocarditis
inferred← citeshttps://doi.org/10.1016/j.sbsr.2025.100914openalex-snapshot
Monitoring TNF-⍺ monoclonal antibody via sweat cytokine profiling using the IBD AWARE®: A non-invasive approach to assess therapeutic response
inferred← citeshttps://doi.org/10.1016/j.sdentj.2023.07.006openalex-snapshot
Correlation of anti-TNF-a biological therapy with periodontal conditions and osteonecrosis in autoimmune patients: A systematic review
inferred← citeshttps://doi.org/10.1016/j.semcancer.2019.05.002openalex-snapshot
Toll-like receptor-induced cytokines as immunotherapeutic targets in cancers and autoimmune diseases
inferred← citeshttps://doi.org/10.1016/j.slasd.2025.100280openalex-snapshot
From Large to Small Cytokine Receptor Antagonists
inferred← citeshttps://doi.org/10.1016/j.smim.2022.101699openalex-snapshot
Development of synthetic lipoxin-A4 mimetics (sLXms): New avenues in the treatment of cardio-metabolic diseases
inferred← citeshttps://doi.org/10.1016/j.smim.2023.101814openalex-snapshot
Immune aging – A mechanism in autoimmune disease
inferred← citeshttps://doi.org/10.1016/j.taap.2017.06.016openalex-snapshot
Inhibitory effect of trans-caryophyllene (TC) on leukocyte-endothelial attachment
inferred← citeshttps://doi.org/10.1016/j.tibtech.2024.05.004openalex-snapshot
Recombinant immune complexes as vaccines against infectious diseases
inferred← citeshttps://doi.org/10.1016/j.tips.2019.04.003openalex-snapshot
Novel Approaches to Persistent Pain Therapy
inferred← citeshttps://doi.org/10.1016/j.trsl.2021.01.004openalex-snapshot
Efficacy of novel bispecific antibody targeting TNF-α/CXCL10 in the treatment of experimental arthritis
inferred← citeshttps://doi.org/10.1016/s0140-6736(24)01451-xopenalex-snapshot
Unlocking the power of NHS research: a priority for the new UK Government
inferred← citeshttps://doi.org/10.1021/acs.analchem.3c00809openalex-snapshot
Integrated Proteomics and Single-Cell Mass Cytometry Analysis Dissects the Immune Landscape of Ankylosing Spondylitis
inferred← citeshttps://doi.org/10.1021/acs.jcim.4c00975openalex-snapshot
Target-Specific De Novo Peptide Binder Design with DiffPepBuilder
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.0c01280openalex-snapshot
Development of Orally Efficacious Allosteric Inhibitors of TNFα via Fragment-Based Drug Design
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5c00323openalex-snapshot
Discovery of Orally Efficacious Bridged Piperazines as smTNF Modulators
inferred← citeshttps://doi.org/10.1021/acs.jnatprod.1c01231openalex-snapshot
A Natural Plant Ingredient, Menthone, Regulates T Cell Subtypes and Lowers Pro-inflammatory Cytokines of Rheumatoid Arthritis
inferred← citeshttps://doi.org/10.1021/acs.jnatprod.6b00554openalex-snapshot
Effects of Koumine on Adjuvant- and Collagen-Induced Arthritis in Rats
inferred← citeshttps://doi.org/10.1021/acs.joc.4c01866openalex-snapshot
Rapid Production of Native and Mirror-Image Tumor Necrosis Factor-α Enabled by Automated Flow Peptide Synthesis Technology
inferred← citeshttps://doi.org/10.1021/acs.jproteome.4c00035openalex-snapshot
Ex-Vivo 13C NMR Spectroscopy of Rodent Brain: TNF Restricts Neuronal Utilization of Astrocyte-Derived Metabolites
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.2c00385openalex-snapshot
Discovery of a Non-competitive TNFR1 Antagonist Affibody with Picomolar Monovalent Potency That Does Not Affect TNFR2 Function
inferred← citeshttps://doi.org/10.1021/acsbiomaterials.3c01765openalex-snapshot
Biparatopic Nanobody-Based Immunosorbent for the Highly Selective Elimination of Tumor Necrosis Factor-α
inferred← citeshttps://doi.org/10.1021/acsomega.1c04797openalex-snapshot
Anti-Inflammatory Effects and Mechanisms of Pudilan Antiphlogistic Oral Liquid
inferred← citeshttps://doi.org/10.1021/acsptsci.9b00097openalex-snapshot
Therapeutic Potential of Lipoxin A4 in Chronic Inflammation: Focus on Cardiometabolic Disease
inferred← citeshttps://doi.org/10.1038/cmi.2017.138openalex-snapshot
Stimulation of TNF receptor type 2 expands regulatory T cells and ameliorates established collagen-induced arthritis in mice
inferred← citeshttps://doi.org/10.1038/ki.2015.162openalex-snapshot
Macrophage-derived tumor necrosis factor-α mediates diabetic renal injury
inferred← citeshttps://doi.org/10.1038/nprot.2016.102openalex-snapshot
Sequencing and cloning of antigen-specific antibodies from mouse memory B cells
inferred← citeshttps://doi.org/10.1038/nrrheum.2015.169openalex-snapshot
TNF biology, pathogenic mechanisms and emerging therapeutic strategies
showing the first 200 of 574 · page through all 574
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.